1 / 17

Two Levels of Enzyme Regulation

Two Levels of Enzyme Regulation. Genetic Level (Enzyme Induction). Definition : Induction is stimulating the synthesis of the enzyme’s messenger RNA. Regulation is based on making more enzyme protein. Substrate Level (covalent modification, allostery).

sakura
Download Presentation

Two Levels of Enzyme Regulation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Two Levels of Enzyme Regulation Genetic Level (Enzyme Induction) Definition: Induction is stimulating the synthesis of the enzyme’s messenger RNA. Regulation is based on making more enzyme protein

  2. Substrate Level (covalent modification, allostery) Substrate level regulates after the enzyme has been synthesized. Regulation is based on activating (or inhibiting) existing enzyme. Covalent Modification: Activate an inactive precursor by removing a blocking peptide or adding or removing phosphate groups Zymogen: An inactive enzyme precursor that requires the removal of a blocking peptide to be active

  3. Covalent Modification: Phosphorylation Glycogen Glycogen phosphorylase b phosphorylase a (less active) (moreactive) The more active form is “a” and the less active is “b”. Adding phosphate to the enzyme stimulates enzyme activity.

  4. B A HO OH OPO3= =O3PO 2ATP 2ADP A B OPO3= OH =O3PO HO 2ATP 2ADP Phosphorylation of Glycogen Enzymes Glycogen phosphorylase (less active) (more active) Glycogen synthase (more active) (less active)

  5. The Hormone Connection Rule: Enzymes that place phosphate groups on proteins are called “protein kinases”. Rule: Protein kinase activity is in part controlled by the level of cyclic AMP within a cell. Rule: Cyclic-AMP mediates the action of some hormones ERGO Rule: Phosphate group modifications explains how hormones such as glucagon, insulin, and epinephrine control enzyme activity in cells

  6. Regulation of Human Gene Expression

  7. What do we know about the Human Genome? Q: How many base pairs are in the human genome? A: Approximately 3.2 billion, i.e., 3.2 x 109 or 3.2 gigabases Q: Of this number how many are protein-encoding components? A: Roughly 1.5 percent Q: Have all of the genes been identified? A: No, we are not even close Q: What is left to do? A: Gene products, i.e., functional mRNAs and proteins, need to be identified, non-coding regulatory sequences need to be understood. Q: What is are best estimate of the number of protein-coding genes? A: Somewhere between 30,000 and 40,000 Q: What about the number of proteins in a human A: Around 120,000

  8. Q: How can there be more proteins than protein-coding genes? A: Humans, more so than any other vertebrate species rely on alternative splicing of a mRNA Q: What to you mean by “alternative” A: That means than one mRNA during processing can be converted into more than one protein-coding mRNA Q: And this is achieved by splicing? A: It all depends on which exons are removed and which are allowed to stay, or which sequences in introns make their way into the final mRNA

  9. Control of Eukaryotic Gene Expression Rule: Regulation of Gene expression comes down to cellular proteins interacting with DNA and RNA Transcription level: enhancers, silencers Post-Transcriptional level: spliceosomes, protein modification What is Gene Silencing and why is this Important? Rule: Opportune turning on or off of genes dictates the spatial and chronological development of an organism Cell, tissue and organ specificity Cell development and differentiation Programmed cell death (apoptosis) Factoid: Practically every gene in eukaryotes is silent when there is no activator to turn the gene on

  10. Barr bodies Polytene Another Look at Mammalian Transcription Rule: Transcription occurs on the surface of highly compact DNA whose unwinding is essential for RNA to assemble Heterochromatin (dense, inactive) Euchromatin (open, active) Chromosome puffs Histones and Nucleosome Structure Nucleosomes Acetylases and deacetylases Left handed DNA in nucleosomes RNA polymerase and + supercoiling

  11. Polytene chromosome (non-transcribed) Enhancers Act Act IIH Nucleosome TAF IIE IIF IIA IIB TATA TBP Pol II Polytene with chromosome puffs Drosophilia Chromosomes RNA Synthesis occurs on chromatin, not DNA TBP TATA box binding Pro. DNA binding domain Activation domain (recruits other proteins) mRNA

  12. Turning a Gene on With a Hormone? Indirectly STATs: (Signal transducers and activators of transcription) • Cell signaling • Protein tyrosine kinases phosphorylate transcription factors that penetrate the nucleus Directly STEROID HORMONES • Steriod hormone receptor proteins that penetrate the nucleus as a protein-steroid complex and bind directly to the promoter region on the DNA • Induce or repress expression of genes • Examples are the glucocorticoid receptor

  13. Cell cycle is controlled by cyclins and cyclin-dependent protein kinases (CDK’s)

  14. How do genes control the cell cycle? Key processes appear to be phosphorylations of nuclear proteins by protein kinases Cyclins and Cyclin kinases Cdc2 kinase in yeast (first to be discovered) 34 kDa protein that phosphorylates threonine and serine residues Activated by the cyclins at S and M phase of the cell cycle Higher Eukaryotes Cyclin-dependent kinases (CDKs) Each transition of cell cycle is triggered by a unique cyclin/kinase complex e.g., CDK2 is required to enter S phase; cdc2, with cyclins A and B regulate mitosis, cdc2 is phosphorylated to enter G2 and dephosphorylated to continue mitosis

  15. Promoter Cyclin genes ADP P ATP Cancer of the Retina Activates E2F Cell proliferation Cyclins Stimulates CDK Inactive Cancer of the retina Rb CDK E2F = a transcription factor that stimulates transcription of cyclin genes Rb = retinoblastoma protein (tumor suppressor)

  16. Promoter pic1 gene CDK Promoter Apoptosis genes ADP ATP P P53 and Cell Death (mutated in 50% of human cancers) Activates Stops mitosis at G1 pic1 pic1-CDK p53 CDK Apoptosis proteins (caspases 3 and 9) Destroys cells, prevents cancer cells from dividing p53 = a transcription activator-tumor suppressor. It accumulates when DNA is damaged. When phosphorylated, p53is a potent activator of genes that stop the cell cycle or kill the cell. If mutated (inactive) p53 allows damaged cells to replicate.

  17. Final Exam for BICH 410 and 601 Monday, December 15, 2003 Room 108 Bio/Bio 10:30- 12:30 Bring Scantron Bring Calculator

More Related